Health
STAT+: HHS moves to allow compounding of some unapproved peptides
Kennedy and his MAHA movement have embraced peptides, though there's little evidence for many of the wellness compounds.
- Published
- (1 h ago)
- Outlet
- STAT News
- Section
- Health
- Length here
- Headline and 18-word snippet. The full article is at the source.
More from STAT News and around the same time
Senate candidate El-Sayed wants to ‘grill’ RFK Jr., calls him the ‘most incompetent HHS secretary ever’Abdul El-Sayed has made headlines for his progressive politics and stance on Israel. But some supporters consider his public health background critical.STAT+: Why every health care AI company must face EpicIn this edition of AI Prognosis: A new investigation into how Epic's market dominance is impacting health tech innovation and AI adoption.STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and moreMissouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B programSTAT+: Lilly’s triple-G drug beats Ozempic in head-to-head studyEli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempic in a large diabetes study.What has actually caused the decline in drug overdose deaths?After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary data from 2025 show another meaningful drop.STAT+: Lilly says ‘triple-G’ drug beats Novo’s Ozempic in diabetes studyData add to expectations that the drug will be one of Lilly’s greatest growth drivers.This page holds the headline and a short snippet as published by STAT News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
